EP2738256A2 - USE OF THE PEPTIDE GK-1 EXPRESSED IN THE FILAMENTOUS PHAGE M13 FOR PREPARING PHARMACEUTICAL PRODUCTS THAT INCREASE THE EFFECTIVENESS OF THE IMMUNE RESPONSE INDUCED BY VACCINE ANTIGENS OR PATHOGENS